2023 was an exciting year for the #biotechnology industry with breakthroughs such as “miracle” weight loss drug GLP-1 and radiopharmaceuticals transforming cancer treatments.
Vertex Ventures HC Managing Directors Christine Brennan and Lori Hu share more about what was interesting from a venture capital perspective.
Find out more about Vertex Ventures HC:
source